DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,422,380 | +6.8% | 5,733 | +3.4% | 0.42% | +115.7% |
| Q2 2023 | $1,331,269 | -0.3% | 5,547 | +4.7% | 0.20% | -50.9% |
| Q1 2023 | $1,335,703 | -4.0% | 5,300 | +1.1% | 0.40% | -8.2% |
| Q4 2022 | $1,390,867 | +3.9% | 5,240 | +5.1% | 0.44% | -5.0% |
| Q3 2022 | $1,339,000 | +8.8% | 4,987 | +6.7% | 0.46% | +16.8% |
| Q2 2022 | $1,231,000 | -9.2% | 4,673 | +1.1% | 0.39% | +3.7% |
| Q1 2022 | $1,356,000 | -11.2% | 4,624 | -0.4% | 0.38% | -5.9% |
| Q4 2021 | $1,527,000 | +9.0% | 4,641 | +0.9% | 0.40% | -1.9% |
| Q3 2021 | $1,401,000 | +13.4% | 4,601 | 0.0% | 0.41% | +13.5% |
| Q2 2021 | $1,235,000 | +22.0% | 4,601 | +2.4% | 0.36% | +12.0% |
| Q1 2021 | $1,012,000 | +6.4% | 4,495 | +5.0% | 0.32% | +26.1% |
| Q4 2020 | $951,000 | +32.3% | 4,280 | +28.1% | 0.26% | -8.5% |
| Q3 2020 | $719,000 | +55.6% | 3,340 | +28.0% | 0.28% | +41.2% |
| Q2 2020 | $462,000 | +33.1% | 2,610 | +4.0% | 0.20% | +11.2% |
| Q1 2020 | $347,000 | -28.2% | 2,510 | -20.2% | 0.18% | -0.6% |
| Q4 2019 | $483,000 | +12.9% | 3,145 | +6.1% | 0.18% | +3.4% |
| Q3 2019 | $428,000 | +77.6% | 2,964 | +75.5% | 0.17% | +75.8% |
| Q2 2019 | $241,000 | +8.1% | 1,689 | 0.0% | 0.10% | +3.1% |
| Q1 2019 | $223,000 | +28.2% | 1,689 | 0.0% | 0.10% | +15.7% |
| Q4 2018 | $174,000 | -4.9% | 1,689 | 0.0% | 0.08% | +18.6% |
| Q3 2018 | $183,000 | +9.6% | 1,689 | +0.1% | 0.07% | +4.5% |
| Q2 2018 | $167,000 | +10.6% | 1,688 | +9.8% | 0.07% | +8.1% |
| Q1 2018 | $151,000 | +21.8% | 1,538 | +15.4% | 0.06% | +26.5% |
| Q4 2017 | $124,000 | +8.8% | 1,333 | 0.0% | 0.05% | +6.5% |
| Q3 2017 | $114,000 | +5.6% | 1,333 | 0.0% | 0.05% | +4.5% |
| Q2 2017 | $108,000 | -6.1% | 1,333 | 0.0% | 0.04% | -12.0% |
| Q1 2017 | $115,000 | +6.5% | 1,333 | 0.0% | 0.05% | +4.2% |
| Q4 2016 | $108,000 | -99.9% | 1,333 | +0.1% | 0.05% | 0.0% |
| Q3 2016 | $101,559,000 | -24.5% | 1,332 | 0.0% | 0.05% | -23.8% |
| Q2 2016 | $134,550,000 | +11.5% | 1,332 | +4.7% | 0.06% | +10.5% |
| Q1 2016 | $120,664,000 | -5.3% | 1,272 | -7.2% | 0.06% | -6.6% |
| Q4 2015 | $127,420,000 | +5.9% | 1,371 | -2.8% | 0.06% | -1.6% |
| Q3 2015 | $120,294,000 | -0.4% | 1,411 | 0.0% | 0.06% | +8.8% |
| Q2 2015 | $120,819,000 | – | 1,411 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |